MedPath

Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression

Not Applicable
Terminated
Conditions
Bipolar Depression
Interventions
Device: active iTBS
Device: sham iTBS
Registration Number
NCT02740244
Lead Sponsor
Hôpital le Vinatier
Brief Summary

The aim is to evaluate the evaluate the clinical interest and the safety of repetitive transcranial magnetic stimulation (rTMS) delivered as intermittent Theta burst stimulation(iTBS) on severity of depression in patients with treatment-resistant bipolar disorder.

Detailed Description

Methods: A double-blind randomized sham-controlled pilot study will be conducted in 40 patients with bipolar treatment-resistant depression receiving either active (n=20) or sham (n=20) iTBS over the left dorsolateral prefrontal cortex.

Depression severity will be assessed by an investigator blinded to iTBS condition before and after 10 to 30 iTBS sessions depending on remission onset. Remission will be defined as Beck Depression Inventory, BDI score\<10.

Objective/Hypothesis: The investigators hypothesized the superiority of active iTBS over sham ITBS

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders, DSM-IV criteria
  • Montgomery and Asberg depression scale > 20
Exclusion Criteria
  • other psychiatric features, rapid cycles
  • Benzodiazepines intake
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
active iTBSactive iTBSParticipants will receive 10 to 30 sessions of active intermittent theta burst stimulation (iTBS) consisting in delivering 2 s train of bursts containing three pulses at 50 Hz repeated each 200 ms every 10 s (iTBS). Each iTBS session contained 990 pulses and lasted 6 min. Stimulation intensity will be set at 80% of the patient's resting motor threshold. iTBS will be applied twice per day, with at least three hours between each session. Ten to 30 sessions will be delivered until patient achieved remission (i.e., 13-item Beck Depression Inventory (BDI13) score \< 10). iTBS will be applied over the left dorsolateral prefrontal cortex (DLPFC) according to the individual's 3D-T1 MRI.
sham iTBSsham iTBSThe same protocol (location, intensity, parameters of stimulation) will be applied using a commercial sham coil.
Primary Outcome Measures
NameTimeMethod
Beck Depression Inventory2 time point measure, before and after the end of stimulation sessions (changes from baseline BDI scores at 6 weeks)

Self-reported clinical scale with 13 items

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath